Divi's Laboratories Limited (DIVISLAB) Stock Statistics & Valuation Metrics

Divi's Laboratories Limited has a market cap or net worth of INR 2.58T. The enterprise value is INR 1.54T.

Market Cap

INR 2.58T

Enterprise Value

INR 1.54T

Divi's Laboratories Limited has 265,468,570 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

265,468,570

Owned by Insiders

―

Owned by Institutions

7.79%

Divi's Laboratories Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 12.55%.

Return on Equity (ROE)

0.15

Return on Assets (ROA)

0.13

Return on Invested Capital (ROIC)

12.55%

Return on Capital Employed (ROCE)

0.17

Revenue Per Employee

9.13M

Profits Per Employee

2.22M

Employee Count

11,565

Asset Turnover

0.53

Inventory Turnover

1.52

The current PE Ratio of Divi's Laboratories Limited is 88.73. Divi's Laboratories Limited’s PEG ratio is 3.30.

PE Ratio

88.73

PS Ratio

23.12

PB Ratio

15.49

Price to FCF

2570.58

Price to Operating Cash Flow

157.83

PEG Ratio

3.30

In the last 12 months, Divi's Laboratories Limited had revenue of 105.60B and earned 25.68B in profits. Earnings per share was 96.75.

Revenue

105.60B

Gross Profit

45.62B

Operating Income

29.78B

Pretax Income

33.88B

Net Income

25.68B

EBITDA

38.74B

Earnings Per Share (EPS)

96.75

In the last 12 months, operating cash flow was 16.45B and capital expenditures -15.44B, giving a free cash flow of 1.01B billion.

Operating Cash Flow

16.45B

Free Cash Flow

1.01B

Free Cash Flow per Share

3.80

Divi's Laboratories Limited pays an annual dividend of INR 30.00, resulting in a dividend yield of 0.31%

Dividend Per Share

INR 30.00

Dividend Yield

0.31%

Payout Ratio

31.01%

Free Cash Flow Yield

0.04%

Earnings Yield

1.13%

Beta

0.80

52-Week Price Change

46.01%

50-Day Moving Average

9288.03

200-Day Moving Average

7335.59

Relative Strength Index (RSI)

63.85

Average Volume (3m)

36.17K

Divi's Laboratories Limited upcoming earnings date is Nov 07, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 01, 2026

Next Earnings Date

Nov 07, 2026

Ex-Dividend Date

Jul 24, 2026

Divi's Laboratories Limited as a current ratio of 5.43, with Debt / Equity ratio of 0.04%

Current Ratio

5.43

Quick Ratio

3.50

Debt to Market Cap

0.00

Net Debt to EBITDA

-0.03

Interest Coverage Ratio

129.48

In the past 12 months, Divi's Laboratories Limited has paid 8.20B in taxes.

Income Tax

8.20B

Effective Tax Rate

0.24

Divi's Laboratories Limited EV to EBITDA ratio is 60.65, with an EV/FCF ratio of 2570.58.

EV to Sales

23.12

EV to EBITDA

60.65

EV to Free Cash Flow

2570.58

EV to Operating Cash Flow

157.83

Divi's Laboratories Limited has INR 32.33B in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 32.33B billion.

Cash & Marketable Securities

INR 32.33B

Total Debt

INR 0.00

Net Cash

INR 32.33B

Net Cash Per Share

INR 121.78

Tangible Book Value Per Share

INR 631.37

Gross margin is 49.85%, with operating margin of 31.02%, and net profit margin of 26.05%.

Gross Margin

49.85%

Operating Margin

31.02%

Pretax Margin

34.15%

Net Profit Margin

26.05%

EBITDA Margin

38.12%

EBIT Margin

33.81%

The average price target for Divi's Laboratories Limited is INR 9,100.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

INR 9,100.00

Price Target Upside

6.33% Downside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

16.35%

EPS Growth Forecast

26.84%

Smart Score

―

AI Score

73